Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CNS | JMKE |
|---|---|---|
| Price | $73.02 | $16.09 |
| Change today | ▲ 0.03% | ▼ 2.90% |
| Market cap | $3.75B | $3.76B |
| Return, 3 months | -7.0% | – |
| Return, year to date | +19.6% | – |
| Return, 1 year | +14.7% | – |
| P/E (TTM) | 22.5 | -146.3 |
| P/B | 6.4 | 0.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 3.53% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +20.5% | +73.7% |
| Analyst buy share | 100% | 83% |
| RSI (14) | 36 | 25 |
| 30-day volatility | 22.7% | 44.6% |
| Max drawdown, 1 year | -16.4% | -34.2% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
